Who is sponsoring NCT00763828?

NCT00763828 is sponsored by Life Recovery Systems.

What drugs are being tested in NCT00763828?

Interventions in NCT00763828: Life Recovery Systems ThermoSuit.

What condition does NCT00763828 study?

NCT00763828 studies ST-Elevation Myocardial Infarction.

Is NCT00763828 still recruiting?

NCT00763828 is currently status unknown. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT00763828: CHIPAHA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?

Status unknown NA Last updated 10 March 2023

What this trial tests

NA trial testing Life Recovery Systems ThermoSuit in ST-Elevation Myocardial Infarction in 20 participants. Status unknown.

Timeline

28 January 2024

Primary endpoint
28 February 2025

31 May 2025

Quick facts

Lead sponsor	Life Recovery Systems
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	28 January 2024
Primary completion	28 February 2025
Estimated completion	31 May 2025
Sites	1 location across United States

Drugs / interventions tested

Life Recovery Systems ThermoSuit

Conditions studied

ST-Elevation Myocardial Infarction — all drugs for ST-Elevation Myocardial Infarction →

Sponsor

Life Recovery Systems — full company profile →

Who can join

18 and older, any sex, with ST-Elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hypothesis of this study is that consciously sedated patients suffering from ST-elevation myocardial infarction can be rapidly and safely cooled to a state of therapeutic hypothermia (32 to 34 degrees C) using the LRS ThermoSuit System prior to percutaneous coronary intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for ST-Elevation Myocardial Infarction

Currently open trials in the same condition.

NCT07444957 — Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease · recruiting

Other Life Recovery Systems trials

Trials by the same sponsor.

NCT02453373 — Helping Stroke Patients With ThermoSuit Cooling · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00763828 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Life Recovery Systems
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00763828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing